NCT02178748View on ClinicalTrials.gov

Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Tuberculosis
Interventions
BIOLOGICAL

MVA85A

Single dose of 1x10\^8pfu MVA85A intramuscular vaccination

Trial Locations (1)

Unknown

MRC/UVRI Uganda Research Unit on AIDS, Entebbe

All Listed Sponsors
collaborator

MRC/UVRI and LSHTM Uganda Research Unit

OTHER

lead

University of Oxford

OTHER

NCT02178748 - Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents | Biotech Hunter | Biotech Hunter